PRODUCT DETAIL

Metoject PEN 27,5 mg injekčný roztok naplnený v injekčnom pere

Code

8961A

MA number

29/0013/14-S

Product Form:

sol ira 1x0,55 ml/27,5 mg (pero napl. BD)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

Therapeutic Class:

29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA

ATC:

L	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04	Immunosuppressants
L04A	Immunosuppressants
L04AX	Other immunosuppressants
L04AX03	Methotrexate

Shelf life:

Container:

pre-filled pen

Route of admin.:

Subcutaneous use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10(3) hybrid application
MA issued:	11.02.2014
Pediatric indication:	Yes
Pediatric posology:	Yes
Pediatric warnings:	Yes
SPC:	SPC_Metoject PEN injekčný roztok naplnený v injekčnom pere_10.2023.pdf
PIL:	PIL_Metoject PEN injekčný roztok naplnený v injekčnom pere_10.2023.pdf
Safety feature	Yes
Data update:	12.10.2023